申请人:KINKI UNIVERSITY
公开号:US20160096815A1
公开(公告)日:2016-04-07
The present invention provides a T-type calcium channel inhibitor which is a compound represented by formula (1), a pharmaceutically acceptable salt of this compound or a solvate of this compound. The present invention also provides: this T-type calcium channel inhibitor; a pharmaceutical product containing this T-type calcium channel inhibitor; and a therapeutic agent or prophylactic agent for diseases, the effective action of which is a T-type calcium channel inhibitory action. (In formula (1), each of R
1
and R
2
independently represents H, —OH or —OR
11
, wherein R
11
represents a C
1-3
alkyl group; each of R
3
and R
4
independently represents H, —OH or —OR
12
, wherein R
12
represents a C
1-3
alkyl group; and each of R
5
and R
6
independently represents H, a halogen atom, a C
1-10
alkyl group, a C
2-6
alkenyl group, a C
2-6
alkynyl group, a phenyl group (which may be substituted by a C
1-6
alkoxy group or a halogen atom), a —C
1-3
alkyl-phenyl group (which may be substituted by a C
1-6
alkyloxy group or a halogen atom) or a C
10-50
prenyl group.)
本发明提供了一种T型钙通道抑制剂,该化合物由式(1)表示,其药学上可接受的盐或该化合物的溶剂。本发明还提供:该T型钙通道抑制剂;含有该T型钙通道抑制剂的药物产品;以及治疗或预防疾病的治疗剂或预防剂,其有效作用是T型钙通道抑制作用。(在式(1)中,每个R1和R2独立地表示H,—OH或—OR11,其中R11表示C1-3烷基;每个R3和R4独立地表示H,—OH或—OR12,其中R12表示C1-3烷基;每个R5和R6独立地表示H,卤素原子,C1-10烷基,C2-6烯基,C2-6炔基,苯基(可能被C1-6烷氧基或卤素原子取代),—C1-3烷基苯基(可能被C1-6烷氧基或卤素原子取代)或C10-50戊二烯基。)